Cabergoline-induced cerebral spinal fluid leak in a patient with a large prolactinoma and MEN1

William Chapin, Christine (Chris) Yedinak, Johnny B. Delashaw, Maria Fleseriu

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Cerebral spinal fluid (CSF) rhinorrhea immediately after the initiation of cabergoline in prolactinoma patients is an uncommon complication that could lead to serious comorbidities and management difficulties. We present a case of a woman with multiple endocrine neoplasia type 1 syndrome and a recurrent macroprolactinoma, who developed CSF rhinorrhea and pneumocephalus after 3 doses of 0.5 mg cabergoline. The patient was treated for sinusitis after complaining of increasing headache. Imaging revealed a large pituitary tumor, skull base erosion, and pneumocephalus. Skull-base defect repair and subsequent transsphenoidal tumor debulking was performed. Prolactin continued to increase postoperatively, and the dopamine agonist (DA) was changed to bromocriptine, with no further CSF leak during 18 months of follow-up.We recommend urgent surgical repair as the treatment of choice for CSF leak following DA treatment. Concurrent surgical tumor debulking should be preformed if possible. Retreatment with DA is a safe option in most cases. To our knowledge, CSF rhinorrhea following cabergoline therapy has not been described in the multiple endocrine neoplasia type 1 syndrome.

Original languageEnglish (US)
Pages (from-to)198-202
Number of pages5
JournalEndocrinologist
Volume20
Issue number4
DOIs
StatePublished - Aug 2010

Fingerprint

Multiple Endocrine Neoplasia Type 1
Prolactinoma
Dopamine Agonists
Pneumocephalus
Multiple Endocrine Neoplasia
Skull Base
Retreatment
Bromocriptine
Sinusitis
Pituitary Neoplasms
Prolactin
Headache
Comorbidity
Neoplasms
Therapeutics
cabergoline

Keywords

  • cabergoline
  • CSF rhinorrhea
  • dopamine agonist
  • MEN1
  • prolactinoma

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Cabergoline-induced cerebral spinal fluid leak in a patient with a large prolactinoma and MEN1. / Chapin, William; Yedinak, Christine (Chris); Delashaw, Johnny B.; Fleseriu, Maria.

In: Endocrinologist, Vol. 20, No. 4, 08.2010, p. 198-202.

Research output: Contribution to journalArticle

@article{ca8f9a30118a43ee958205a078e19e5d,
title = "Cabergoline-induced cerebral spinal fluid leak in a patient with a large prolactinoma and MEN1",
abstract = "Cerebral spinal fluid (CSF) rhinorrhea immediately after the initiation of cabergoline in prolactinoma patients is an uncommon complication that could lead to serious comorbidities and management difficulties. We present a case of a woman with multiple endocrine neoplasia type 1 syndrome and a recurrent macroprolactinoma, who developed CSF rhinorrhea and pneumocephalus after 3 doses of 0.5 mg cabergoline. The patient was treated for sinusitis after complaining of increasing headache. Imaging revealed a large pituitary tumor, skull base erosion, and pneumocephalus. Skull-base defect repair and subsequent transsphenoidal tumor debulking was performed. Prolactin continued to increase postoperatively, and the dopamine agonist (DA) was changed to bromocriptine, with no further CSF leak during 18 months of follow-up.We recommend urgent surgical repair as the treatment of choice for CSF leak following DA treatment. Concurrent surgical tumor debulking should be preformed if possible. Retreatment with DA is a safe option in most cases. To our knowledge, CSF rhinorrhea following cabergoline therapy has not been described in the multiple endocrine neoplasia type 1 syndrome.",
keywords = "cabergoline, CSF rhinorrhea, dopamine agonist, MEN1, prolactinoma",
author = "William Chapin and Yedinak, {Christine (Chris)} and Delashaw, {Johnny B.} and Maria Fleseriu",
year = "2010",
month = "8",
doi = "10.1097/TEN.0b013e3181e94b87",
language = "English (US)",
volume = "20",
pages = "198--202",
journal = "Endocrinologist",
issn = "1051-2144",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Cabergoline-induced cerebral spinal fluid leak in a patient with a large prolactinoma and MEN1

AU - Chapin, William

AU - Yedinak, Christine (Chris)

AU - Delashaw, Johnny B.

AU - Fleseriu, Maria

PY - 2010/8

Y1 - 2010/8

N2 - Cerebral spinal fluid (CSF) rhinorrhea immediately after the initiation of cabergoline in prolactinoma patients is an uncommon complication that could lead to serious comorbidities and management difficulties. We present a case of a woman with multiple endocrine neoplasia type 1 syndrome and a recurrent macroprolactinoma, who developed CSF rhinorrhea and pneumocephalus after 3 doses of 0.5 mg cabergoline. The patient was treated for sinusitis after complaining of increasing headache. Imaging revealed a large pituitary tumor, skull base erosion, and pneumocephalus. Skull-base defect repair and subsequent transsphenoidal tumor debulking was performed. Prolactin continued to increase postoperatively, and the dopamine agonist (DA) was changed to bromocriptine, with no further CSF leak during 18 months of follow-up.We recommend urgent surgical repair as the treatment of choice for CSF leak following DA treatment. Concurrent surgical tumor debulking should be preformed if possible. Retreatment with DA is a safe option in most cases. To our knowledge, CSF rhinorrhea following cabergoline therapy has not been described in the multiple endocrine neoplasia type 1 syndrome.

AB - Cerebral spinal fluid (CSF) rhinorrhea immediately after the initiation of cabergoline in prolactinoma patients is an uncommon complication that could lead to serious comorbidities and management difficulties. We present a case of a woman with multiple endocrine neoplasia type 1 syndrome and a recurrent macroprolactinoma, who developed CSF rhinorrhea and pneumocephalus after 3 doses of 0.5 mg cabergoline. The patient was treated for sinusitis after complaining of increasing headache. Imaging revealed a large pituitary tumor, skull base erosion, and pneumocephalus. Skull-base defect repair and subsequent transsphenoidal tumor debulking was performed. Prolactin continued to increase postoperatively, and the dopamine agonist (DA) was changed to bromocriptine, with no further CSF leak during 18 months of follow-up.We recommend urgent surgical repair as the treatment of choice for CSF leak following DA treatment. Concurrent surgical tumor debulking should be preformed if possible. Retreatment with DA is a safe option in most cases. To our knowledge, CSF rhinorrhea following cabergoline therapy has not been described in the multiple endocrine neoplasia type 1 syndrome.

KW - cabergoline

KW - CSF rhinorrhea

KW - dopamine agonist

KW - MEN1

KW - prolactinoma

UR - http://www.scopus.com/inward/record.url?scp=77955232719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955232719&partnerID=8YFLogxK

U2 - 10.1097/TEN.0b013e3181e94b87

DO - 10.1097/TEN.0b013e3181e94b87

M3 - Article

VL - 20

SP - 198

EP - 202

JO - Endocrinologist

JF - Endocrinologist

SN - 1051-2144

IS - 4

ER -